These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15123712)

  • 1. The solution structure of the N-terminal domain of human vitronectin: proximal sites that regulate fibrinolysis and cell migration.
    Mayasundari A; Whittemore NA; Serpersu EH; Peterson CB
    J Biol Chem; 2004 Jul; 279(28):29359-66. PubMed ID: 15123712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the native disulfide topology in the somatomedin B domain of human vitronectin.
    Li X; Zou G; Yuan W; Lu W
    J Biol Chem; 2007 Feb; 282(8):5318-26. PubMed ID: 17189256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional structure of the somatomedin B domain of vitronectin.
    Zhou A
    Protein Sci; 2007 Jul; 16(7):1502-8. PubMed ID: 17567740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin.
    Kamikubo Y; De Guzman R; Kroon G; Curriden S; Neels JG; Churchill MJ; Dawson P; Ołdziej S; Jagielska A; Scheraga HA; Loskutoff DJ; Dyson HJ
    Biochemistry; 2004 Jun; 43(21):6519-34. PubMed ID: 15157085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of recombinant somatomedin B domain from vitronectin produced in Pichia pastoris.
    Kjaergaard M; Gårdsvoll H; Hirschberg D; Nielbo S; Mayasundari A; Peterson CB; Jansson A; Jørgensen TJ; Poulsen FM; Ploug M
    Protein Sci; 2007 Sep; 16(9):1934-45. PubMed ID: 17766387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an Extensive Interface on Vitronectin for Binding to Plasminogen Activator Inhibitor-1: Adoption of Structure in an Intrinsically Disordered Region.
    Puster LO; Stanley CB; Uversky VN; Curtis JE; Krueger S; Chu Y; Peterson CB
    Biochemistry; 2019 Dec; 58(51):5117-5134. PubMed ID: 31793295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domain.
    Schar CR; Jensen JK; Christensen A; Blouse GE; Andreasen PA; Peterson CB
    J Biol Chem; 2008 Oct; 283(42):28487-96. PubMed ID: 18658131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangements.
    Blouse GE; Dupont DM; Schar CR; Jensen JK; Minor KH; Anagli JY; Gårdsvoll H; Ploug M; Peterson CB; Andreasen PA
    Biochemistry; 2009 Mar; 48(8):1723-35. PubMed ID: 19193026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assignment of the four disulfides in the N-terminal somatomedin B domain of native vitronectin isolated from human plasma.
    Horn NA; Hurst GB; Mayasundari A; Whittemore NA; Serpersu EH; Peterson CB
    J Biol Chem; 2004 Aug; 279(34):35867-78. PubMed ID: 15173163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for defining binding sites involved in protein-protein interactions: analysis of the binding of plasminogen activator inhibitor 1 to the somatomedin domain of vitronectin.
    Royle G; Deng G; Seiffert D; Loskutoff DJ
    Anal Biochem; 2001 Sep; 296(2):245-53. PubMed ID: 11554720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reduced, denatured somatomedin B domain of vitronectin refolds into a stable, biologically active molecule.
    Kamikubo Y; Kroon G; Curriden SA; Dyson HJ; Loskutoff DJ
    Biochemistry; 2006 Mar; 45(10):3297-306. PubMed ID: 16519524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin.
    Deng G; Curriden SA; Hu G; Czekay RP; Loskutoff DJ
    J Cell Physiol; 2001 Oct; 189(1):23-33. PubMed ID: 11573201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.
    Schroeck F; Arroyo de Prada N; Sperl S; Schmitt M; Viktor M
    Biol Chem; 2002; 383(7-8):1143-9. PubMed ID: 12437099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity.
    Schar CR; Blouse GE; Minor KH; Peterson CB
    J Biol Chem; 2008 Apr; 283(16):10297-309. PubMed ID: 18174166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration.
    Zhou A; Huntington JA; Pannu NS; Carrell RW; Read RJ
    Nat Struct Biol; 2003 Jul; 10(7):541-4. PubMed ID: 12808446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a PAI-1-binding site within an intrinsically disordered region of vitronectin.
    Chu Y; Bucci JC; Peterson CB
    Protein Sci; 2020 Feb; 29(2):494-508. PubMed ID: 31682300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen/deuterium exchange mass spectrometry reveals specific changes in the local flexibility of plasminogen activator inhibitor 1 upon binding to the somatomedin B domain of vitronectin.
    Trelle MB; Hirschberg D; Jansson A; Ploug M; Roepstorff P; Andreasen PA; Jørgensen TJ
    Biochemistry; 2012 Oct; 51(41):8256-66. PubMed ID: 22957734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.
    Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ
    Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper(II) Ions Increase Plasminogen Activator Inhibitor Type 1 Dynamics in Key Structural Regions That Govern Stability.
    Bucci JC; Trelle MB; McClintock CS; Qureshi T; Jørgensen TJ; Peterson CB
    Biochemistry; 2016 Aug; 55(31):4386-98. PubMed ID: 27416303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1.
    Li SH; Reinke AA; Sanders KL; Emal CD; Whisstock JC; Stuckey JA; Lawrence DA
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4941-9. PubMed ID: 24297881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.